KalVista Pharmaceuticals (KALV) Other Operating Expenses (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Other Operating Expenses of $590000.0 in Q3 2025, up 106.17% quarter-over-quarter from -$9.6 million in Q1 2017.
KalVista Pharmaceuticals' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $590000.0 for Q3 2025.
- In Q3 2025, Other Operating Expenses changed N/A year-over-year to $590000.0; the TTM figure through Jul 2025 stood at $590000.0 (changed N/A YoY), while the FY2025 annual figure was -$53.4 million, down 49.25% from the prior year.
- Other Operating Expenses came in at $590000.0 for Q3 2025 at KalVista Pharmaceuticals, up from -$9.6 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $590000.0 in Q3 2025 to a low of $590000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 590,000.00 |
| Jan 31, 2017 | -9.56 Mn |
| Oct 31, 2016 | 1,000.00 |
| Mar 31, 2016 | 1.46 Mn |
| Dec 31, 2015 | -1,000.00 |
| Dec 31, 2014 | 3.83 Mn |